Neha Sharma

Neha Sharma

Auto-generated profile, based on publicly available information

Neha Sharma

Department of Pharmacology, School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road,Phagwara, Punjab, India

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2019 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
BUBashir Usman
Bashir Usman
NSNeha Sharma
Neha Sharma
SSSaurabh Satija
Saurabh Satija
MMMeenu Mehta
Meenu Mehta
MVManish Vyas
Manish Vyas
Kamal DuaKamal Dua
Kamal Dua
The incidence of diabetes has increased globally in recent years and figures of diabetic patients were estimated to rise up to 642 million by 2040. The disorder is accompanied with various complications if not managed at the early stages, and interlinked high mortality rate and morbidity with time. Different classes of drugs are available for the management of type 2 diabetes but were having certain limitations of their safety. Alphaglucosidase is a family of enzyme originated from the pancreas which plays a role in the anabolism of 80-90% of carbohydrate consumed into glucose. This glucose is absorbed into the blood and results in frank postprandial hyperglycemia and worsens the conditions of diabetic patients which precipitate complications. Inhibition of these enzymes helps to prevent postprandial hyperglycemia and the formation of glycated end products. Alphaglucosidase inhibitors are reported to be more important in adequate control of type 2, but marketed drugs have various side effects, such as poor patient compliance and also expensive. This proves the needs for other class of drugs with better efficacy, safety, patient compliance and economic. In this review, we have emphasized the recent advances in the field of new alpha-glucosidase inhibitors with improved safety and pharmacological profile.

1 October 2021 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
SHSadique Hussain
Sadique Hussain
PSParvarish Sharma
Parvarish Sharma
DDDaljeet Singh Dhanjal
Daljeet Singh Dhanjal
NKNavneet Khurana
Navneet Khurana
MVManish Vyas
Manish Vyas
HSHari S. Sharma
Hari S. Sharma

1 August 2021 in South African Journal of Botany
Verified
Journal Article
Open access
RKRajan Kumar
Rajan Kumar
RKRakesh Kumar
Rakesh Kumar
RKRubiya Khursheed
Rubiya Khursheed
AAAnkit Awasthi
Ankit Awasthi
NKNavneet Khurana
Navneet Khurana
LCLeander Corrie
Leander Corrie

1 July 2021 in European Journal of Pharmacology
Verified
Journal Article
Closed access
NSNeha Sharma
Neha Sharma
NKNavneet Khurana
Navneet Khurana
AMArunachalam Muthuraman
Arunachalam Muthuraman
PUPuneet Utreja
Puneet Utreja

1 November 2021 in European Journal of Pharmacology
Verified
Journal Article
Closed access
RKRakesh Kumar
Rakesh Kumar
RKRajan Kumar
Rajan Kumar
NSNeha Sharma
Neha Sharma
NKNavneet Khurana
Navneet Khurana

16 September 2017 in Asian Journal of Pharmaceutical and Clinical Research
Verified
Journal Article
Open access
AAAbhinav Anand
Abhinav Anand
NSNeha Sharma
Neha Sharma
NKNavneet Khurana
Navneet Khurana
Objective: To predict the biological activity of certain phytoconstituents for their anti-AD effects.Methods: Several phytoconstituents were selected on the basis of reported literature. The anti-AD activities of selected phytoconstituents were predicted by employing canonical simplified molecular-input line-entry system obtained from PubChem using PASS online.Results: Several phytoconstituents were predicted to have effects better than marketed drugs under some or the other out of the chosen six areas of pharmacological intervention. On the other hand, several new avenues were predicted in which the in vitro and in vivo evaluation of the phytoconstituents can be made on the basis of PASS predicted activities.Conclusion: PASS is an important tool for virtually screening the compounds of interest for the biological activities of interest. This helps the researchers to streamline the research. However, PASS has its own share of limitations amidst a multitude of merits.